Harness IP
  • People
  • Global IP Services
    • Practice Areas
    • Industries
    • Case Studies
  • Blog
  • News & Awards
  • About Us
    • Careers
    • Offices
  • Contact Us
  • Client Login

Blog

Subscribe to our Blogs

  • Subscribe to our Blogs

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible. 

  • Biologics & Biosimilars

      ALL CATEGORIES

      • Biologics & Biosimilars
      • BioPharma
      • Chemistry & Nanotechnology
      • Fitness IP
      • IP Management
      • IPR-PGR
      • Litigation
      • Patent Prosecution
      • quIPs
      • Trademarks
  • Authors
    • John H. Ambrose, Jr.John H. Ambrose, Jr. 2
    • Jewell N. BriggsJewell N. Briggs 8
    • Elizabeth K. BrockElizabeth K. Brock 7
    • Christopher M. CaubleChristopher M. Cauble 3
    • William J. CoughlinWilliam J. Coughlin 1
    • Matthew L. CutlerMatthew L. Cutler 194
    • Donald J. DaleyDonald J. Daley 1
    • Nicholas S. DrysdaleNicholas S. Drysdale 7
    • Monte L. FalcoffMonte L. Falcoff 3
    • Glenn E. ForbisGlenn E. Forbis 11
    • Michael GambleMichael Gamble 1
    • Jason A. HeistJason A. Heist 1
    • Michael P. KellaMichael P. Kella 1
    • Hemant M. KeskarHemant M. Keskar 4
    • Sung Pil KimSung Pil Kim 1
    • Elisabeth A. KoralElisabeth A. Koral 10
    • Kisuk LeeKisuk Lee 1
    • Chris K. MillerChris K. Miller 1
    • Joshua A. PartingtonJoshua A. Partington 4
    • Leanne M. RakersLeanne M. Rakers 26
    • Douglas A. RobinsonDouglas A. Robinson 17
    • Joel R. SamuelsJoel R. Samuels 16
    • Jeffrey L. SnyderJeffrey L. Snyder 1
    • David L. SuterDavid L. Suter 2
    • Michael L. TaylorMichael L. Taylor 1
    • Jennifer R. TurchynJennifer R. Turchyn 4
    • Michael VarcoMichael Varco 3
    • Joseph E. Walsh, Jr.Joseph E. Walsh, Jr. 1
    • Andrew M. WaxmanAndrew M. Waxman 2
    • Bryan K. WheelockBryan K. Wheelock 674
    • Jennifer M. Woodside WojtalaJennifer M. Woodside Wojtala 12
    • Scott E. YackeyScott E. Yackey 1
    • Paul E. Zarek, Ph.D.Paul E. Zarek, Ph.D. 3

  • October 7, 2021

    THIS forum selection clause in THIS NDA agreement did not bar the IPRs

    More

  • Business Person Applying for a Design Patent

    October 4, 2021

    What’s in a Name? Patentability.

    More

  • September 20, 2021

    §101: Why We Won’t Have Nice Things

    More

  • why you shouldn't listen to a non patent attorney

    September 8, 2021

    Why You Shouldn’t Listen to Patent Advice From Non-lawyers, Including Podcast Hosts

    More

  • Patent Law Attorneys Harness IP

    September 6, 2021

    There’s More to Being an Inventor than Butterscotch Ripple

    More

  • Trademark Enforcement Attorneys

    September 1, 2021

    False Association Under 2(a) is not the Same As Likelihood of Confusion Under 2(d)

    More

September 20, 2019

FDA Publishes New Guidance Limiting Petitions that Could Delay Biosimilar Applications

By: Leanne M. Rakers, Principal

photo of biosimilar medications

February 7, 2019

Abandoning Infringing Conduct Caused Loss of Standing to Appeal IPR

By: Bryan K. Wheelock, Principal

Harness IP Intellectual Property Lawyers

August 20, 2018

Pfizer’s Biosimilar Antitrust Lawsuit Survives Johnson & Johnson’s Motion to Dismiss

By: Elisabeth A. Koral, Principal

photo of laboratory and scientist creating biosimilar patents

August 9, 2018

FDA Implements Biosimilar Action Plan to Boost Biosimilar Competition

By: Leanne M. Rakers, Principal

image of light bulb to suggest hypothetical biosimilar case study

August 9, 2018

At Risk Launch: A Hypothetical Case Study

By: Douglas A. Robinson, Principal

photo of chess pieces representing biosimilar competitive dynamics

August 8, 2018

Competitor Influence on the Conduct of the Patent Dance and Litigation

By: Elisabeth A. Koral, Principal

photo of biosimilar medications

August 7, 2018

Seeking Biosimilar Market Entry When a Competitor is Pursuing Interchangeability: Factors to Consider

By: Elisabeth A. Koral, Principal

Stay current

  • Subscribe to our Blogs
  • Twitter
  • Facebook
  • LinkedIn
    • Sitemap
    • Privacy Statement
    • Legal Notice

  • © 2021 Harness, Dickey & Pierce, P.L.C. All rights reserved.